These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients]. Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033 [No Abstract] [Full Text] [Related]
5. Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients. Veneri D; Zanetti F; Franchini M; Krampera M; Pizzolo G Haematologica; 2002 Nov; 87(11):ELT43. PubMed ID: 12414364 [No Abstract] [Full Text] [Related]
6. [Comparison of two multi-drug chemotherapy regimens based on mitoxantrone and epirubicin in 44 patients with non-Hodgkin's lymphoma]. Gao HR Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):287-90. PubMed ID: 1806350 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma]. Rolski J; Koralewski P; Pawlicki M Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992 [TBL] [Abstract][Full Text] [Related]
8. Results of three polychemotherapy programs in non-Hodgkin's lymphomas. Konopka L; Pawelski S J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857 [No Abstract] [Full Text] [Related]
9. [Primary non-Hodgkin's lymphoma of the thyroid. A case report and review of the literature]. Belcadhi M; el Omri H; Gnaba K; Mani R; Abdelkefi M; Bouzouita K; Ennabli S; Bouzouita H Tunis Med; 2003 Feb; 81(2):130-3. PubMed ID: 12708180 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone. Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771 [TBL] [Abstract][Full Text] [Related]
11. [Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas]. Baĭsogolov GD; Shakhtarina SV; Polonskaia NIu; Davydov VA Med Radiol (Mosk); 1989 Aug; 34(8):31-6. PubMed ID: 2770444 [No Abstract] [Full Text] [Related]
12. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group. Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R Semin Hematol; 1994 Apr; 31(2 Suppl 3):32-5. PubMed ID: 8073307 [No Abstract] [Full Text] [Related]
13. Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma. Kim JG; Sohn SK; Kim DH; Baek JH; Park TI; Lee KB J Korean Med Sci; 2004 Dec; 19(6):820-5. PubMed ID: 15608392 [TBL] [Abstract][Full Text] [Related]
14. Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas. Abate G; Comella P; Di Pietro N; Ganzina F; Pergola M; Silvestro P; Basso A; Salvatore M; Zarrilli D Tumori; 1987 Feb; 73(1):43-7. PubMed ID: 3469805 [TBL] [Abstract][Full Text] [Related]
15. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology]. Tominaga S; Kondo M Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551 [No Abstract] [Full Text] [Related]
16. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma]. Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516 [No Abstract] [Full Text] [Related]
17. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP]. Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470 [No Abstract] [Full Text] [Related]
18. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group). Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536 [TBL] [Abstract][Full Text] [Related]
19. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy]. Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347 [No Abstract] [Full Text] [Related]
20. [CEOP regimen in the treatment for non-Hodgkin's lymphoma]. Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]